GS-441524 and remdesivir: where we started and what we have learnt
Overview
Learning Objectives:
- Summarise the evidence supporting GS-441524 and remdesivir as effective treatments for FIP.
- Explain current consensus recommendations (ISCAID treatment guideline) regarding first-line antiviral therapy for FIP.
- Compare GS-441524 and remdesivir with other nucleoside analogues in terms of evidence and clinical outcomes.
- Describe key lessons learned about dose optimisation and preferred route of administration across different clinical presentations of FIP.
Presenters
By the end of this webinar, participants should be able to:
Explain key information caregivers need…
Supportive care: treating FIP is more than just antivirals Register here Already registered Overview…
By the end of this lecture, participants will be able to:
Describe the epidemiology, transmission…
Load More
